APA (7th ed.) Citation

Henderson, R. H., French, D., Stewart, E., Smart, D., Idica, A., Redmond, S., . . . Lawler, M. (2023). Delivering the precision oncology paradigm: Reduced R&D costs and greater return on investment through a companion diagnostic informed precision oncology medicines approach. Journal of Pharmaceutical Policy & Practice, 16(1), 1. https://doi.org/10.1186/s40545-023-00590-9

Chicago Style (17th ed.) Citation

Henderson, Raymond H., et al. "Delivering the Precision Oncology Paradigm: Reduced R&D Costs and Greater Return on Investment Through a Companion Diagnostic Informed Precision Oncology Medicines Approach." Journal of Pharmaceutical Policy & Practice 16, no. 1 (2023): 1. https://doi.org/10.1186/s40545-023-00590-9.

MLA (9th ed.) Citation

Henderson, Raymond H., et al. "Delivering the Precision Oncology Paradigm: Reduced R&D Costs and Greater Return on Investment Through a Companion Diagnostic Informed Precision Oncology Medicines Approach." Journal of Pharmaceutical Policy & Practice, vol. 16, no. 1, 2023, p. 1, https://doi.org/10.1186/s40545-023-00590-9.